Dss, Inc. · AMEX:DSS
Heng Fai Ambrose Chan reported a 86.30% stake in Dss, Inc. (Schedule 13D/A)
Event Sep 3, 2026 · Filed Sep 8, 2026
Heng Fai Ambrose Chan reported a 86.30% stake in Dss, Inc., 26,311,715 shares, with active intent on Sep 3, 2026. Filed Sep 8, 2026 (Schedule 13D/A).
- Stake
- 86.30%
- Shares
- 26,311,715
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Heng Fai Ambrose Chan | 86.30% | 26,311,715 |
| Alset Inc. | 80.00% | 24,407,472 |
| Global Biomedical Pte. Ltd. | 3.10% | 311,634 |
| Alset International Limited | 71.00% | 21,244,809 |
Source
Related
- Dss, Inc.
- Heng Fai Ambrose Chan
- Dss, Inc. shareholders
- Schedule 13D/A · Heng Fai Ambrose Chan · Jul 9, 2026
- Schedule 13D/A · Heng Fai Ambrose Chan · Sep 2, 2025
- Schedule 13D/A · Heng Fai Ambrose Chan · Aug 22, 2025
- Schedule 13D/A · Heng Fai Ambrose Chan · Feb 10, 2025
- Form 4 · Heng Fai Ambrose Chan · Sep 8, 2026